Tempus AI (NASDAQ:TEM) EVP Sells $231,552.82 in Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps sold 3,533 shares of the company’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $65.54, for a total transaction of $231,552.82. Following the completion of the sale, the executive vice president directly owned 90,582 shares of the company’s stock, valued at $5,936,744.28. The trade was a 3.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Tempus AI Price Performance

Shares of TEM traded down $3.40 during trading hours on Thursday, hitting $65.69. 7,149,431 shares of the company were exchanged, compared to its average volume of 11,236,510. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $104.32. The company has a market capitalization of $11.69 billion, a PE ratio of -55.20 and a beta of 4.86. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12. The firm has a fifty day simple moving average of $84.42 and a 200-day simple moving average of $71.91.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. The firm had revenue of $334.21 million for the quarter, compared to analysts’ expectations of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.Tempus AI’s revenue was up 84.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.46) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on TEM shares. Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Guggenheim lifted their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 26th. Piper Sandler lowered their price target on Tempus AI from $105.00 to $80.00 and set a “neutral” rating on the stock in a report on Tuesday, November 11th. Morgan Stanley lifted their price objective on Tempus AI from $68.00 to $80.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 11th. Finally, BTIG Research reiterated a “buy” rating and set a $96.00 target price on shares of Tempus AI in a research note on Wednesday, November 5th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $80.00.

Institutional Investors Weigh In On Tempus AI

A number of hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after buying an additional 5,900,668 shares during the last quarter. ARK Investment Management LLC raised its stake in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after acquiring an additional 1,981,755 shares during the last quarter. Voloridge Investment Management LLC boosted its holdings in shares of Tempus AI by 183.0% in the 3rd quarter. Voloridge Investment Management LLC now owns 1,607,083 shares of the company’s stock worth $129,708,000 after acquiring an additional 1,039,176 shares in the last quarter. Nikko Asset Management Americas Inc. boosted its holdings in shares of Tempus AI by 31.5% in the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after acquiring an additional 1,021,460 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its position in Tempus AI by 312.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,274,549 shares of the company’s stock worth $102,869,000 after acquiring an additional 965,730 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.